<DOC>
	<DOCNO>NCT03003416</DOCNO>
	<brief_summary>This study evaluate efficacy Ozurdex® prescribe clinical practice France treatment Diabetic Macular Edema ( DME ) .</brief_summary>
	<brief_title>Efficacy Ozurdex® Treatment Diabetic Macular Edema ( DME )</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Patient Diabetic Macular Edema ( DME ) treat Ozurdex® clinical practice . Patient reside metropolitan France .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>